Vadivarhe Speciality Chemicals promoters declare no encumbrances

1 min read     Updated on 03 Jun 2026, 09:10 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Vadivarhe Speciality Chemicals disclosed that its promoters and promoter group hold no encumbrances on equity shares as of March 31, 2026. The filing was made under SEBI regulations, confirming that the 66.83% stake held by the promoter group is free from liens or charges.

powered bylight_fuzz_icon
42003594

*this image is generated using AI for illustrative purposes only.

Vadivarhe Speciality Chemicals has disclosed that its promoters and promoter group have not created any encumbrances on their equity shareholdings as of March 31, 2026. This declaration was submitted to the National Stock Exchange of India in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the shares held by the promoters are free from liens or charges, which is a key indicator of financial stability for shareholders.

The disclosure was made by Sunil Haripant Pophale, a promoter of the company, on behalf of all promoters and persons acting in concert. The submission covers the financial year ended March 31, 2026. The company's Board and the Audit Committee were also furnished with this information as part of the regulatory compliance process.

Shareholding Details

The promoter group, comprising individuals and corporate entities, holds a significant portion of the company's equity. The total shareholding of the promoter group stands at 85,42,250 shares, representing 66.83% of the total share or voting capital. The detailed breakdown of the shareholding and the status of encumbrances is provided in the table below.

Name of Promoter(s), member of the promoter group and Persons Acting in Concert (PAC) No. of Shares % w.r.t. total share/ voting capital wherever applicable No. of shares encumbered
Sunil Haripant Pophale 1001000 7.83% NIL
Meena Sunil Pophale 6038000 47.24% NIL
Manasi Sunil Pophale 250 0.00% NIL
Aditi Sunil Pophale 1500000 11.74% NIL
Sunita Ajay Ramnathkar 3000 0.02% NIL
Reelabs Private Limited - - -
Starkutmedia and Entertainment Private Limited - - -
Pophale International LLP - - -
Zenvision Pharma LLP - - -
Respect Labs LLP - - -
Cevitr Limited - - -
Total 85,42,250 66.83% NIL

The table indicates that none of the shares held by the promoters or the promoter group entities are encumbered. This includes shares held by individual promoters such as Meena Sunil Pophale, who holds the largest stake at 47.24%, as well as shares held by various private limited companies and LLPs associated with the promoters.

Historical Stock Returns for Vadivarhe Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.02%-0.59%+30.15%-24.40%+87.73%

How might this clean shareholding status influence Vadivarhe Speciality Chemicals' ability to secure future financing or debt?

Does the lack of encumbrances suggest the promoters are preparing for a potential stake sale or strategic partnership in the near future?

How will the company utilize the strong promoter backing to fund expansion or R&D initiatives in the upcoming fiscal year?

Vadivarhe Speciality Chemicals
View Company Insights
View All News
like20
dislike

Vadivarhe reports FY26 net loss of ₹163.77 lakh

1 min read     Updated on 29 May 2026, 01:03 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Vadivarhe Speciality Chemicals approved audited financial results for FY26, reporting a net loss of ₹163.77 lakh versus a loss of ₹926.53 lakh in the previous year, while revenue rose to ₹4,578.03 lakh. The statutory auditors issued an unmodified opinion but highlighted material uncertainties regarding the company's ability to continue as a going concern due to eroded net worth. The board also appointed M/s. Yatin and Associates as internal auditors for FY27.

powered bylight_fuzz_icon
41317166

*this image is generated using AI for illustrative purposes only.

Vadivarhe Speciality Chemicals reported a net loss of ₹163.77 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹926.53 lakh in the previous year. The board approved the audited financial results for the half year and financial year ended March 31, 2026, during a meeting held on May 28, 2026. Revenue from operations for the year stood at ₹4,578.03 lakh, up from ₹3,790.53 lakh in FY25. For the half year ended March 31, 2026, the company posted a profit of ₹221.48 lakh.

S. R. Rahalkar & Associates, Statutory Auditors, issued an audit report with an unmodified opinion on the standalone financial results. However, the auditors included an emphasis of matter paragraph noting that the company has accumulated losses and its net worth has been fully eroded. The report states that current liabilities exceed current assets, indicating a material uncertainty about the company's ability to continue as a going concern. Management represented that confirmed orders in hand are expected to generate substantial cash flows and improve the financial position.

The board appointed M/s. Yatin and Associates, Chartered Accountants, as internal auditors for the financial year 2026-27. The firm is headed by CA Yatin Patwardhan and comprises a team of 24 professionals. The trading window for dealing in the company's securities, which closed on April 01, 2026, will reopen 48 hours after the declaration of the audited financial results.

Financial Performance

Particulars Year Ended 31/03/2026 (₹ in Lakhs) Year Ended 31/03/2025 (₹ in Lakhs)
Revenue from Operations 4,578.03 3,790.53
Total Revenue 4,640.63 3,817.45
Total Expenses 4,836.61 4,749.73
Profit/Loss for the Period (163.77) (926.53)
Basic EPS (₹) (1.28) (7.25)

Key Meeting Details

Agenda Item Details
Meeting Date May 28, 2026
Meeting Mode Video Conferencing / Other Audio-Visual Means
Financial Period Half year and Financial Year ended March 31, 2026
Trading Window Closure April 01, 2026

Historical Stock Returns for Vadivarhe Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.02%-0.59%+30.15%-24.40%+87.73%

What specific timeline does management anticipate for converting the confirmed orders into cash flow to resolve the going concern uncertainty?

Will the company need to raise additional equity or debt capital to bridge the gap between current liabilities and assets?

How will the appointment of the new internal auditor impact the company's cost control and financial compliance strategies in FY27?

Vadivarhe Speciality Chemicals
View Company Insights
View All News
like18
dislike

More News on Vadivarhe Speciality Chemicals

1 Year Returns:-24.40%